Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolun Zhou

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|April 23, 2020
Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal TractBolun Zhou, Yutong Yuan, Shanshan Zhang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 2, 2024
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing dataYang Liu, Fenglong Bie, Guangyu Bai, et al.
International Immunopharmacology|May 3, 2022
Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinomaBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Ebiomedicine|March 21, 2022
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based studyBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Chinese Medical Journal|March 20, 2025
Real-world long-term outcomes of non-small cell lung cancer patients undergoing neoadjuvant treatment with or without immune checkpoint inhibitorsBolun Zhou, Lin Li, Fan Zhang, et al.
Pharmacological Research|September 14, 2023
Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non-small cell lung cancerWei Guo, Bolun Zhou, Liang Zhao, et al.
Translational Lung Cancer Research|September 12, 2022
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodesBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Ebiomedicine|September 18, 2022
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancerBolun Zhou, Fenglong Bie, Ruochuan Zang, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2022
Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancerWei Guo, Qilin Huai, Bolun Zhou, et al.
Journal of Cellular and Molecular Medicine|September 3, 2019
Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancersWei Zhu, Bolun Zhou, Chenxuan Zhao, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|April 23, 2020
Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal TractBolun Zhou, Yutong Yuan, Shanshan Zhang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 2, 2024
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing dataYang Liu, Fenglong Bie, Guangyu Bai, et al.
International Immunopharmacology|May 3, 2022
Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinomaBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Ebiomedicine|March 21, 2022
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based studyBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Chinese Medical Journal|March 20, 2025
Real-world long-term outcomes of non-small cell lung cancer patients undergoing neoadjuvant treatment with or without immune checkpoint inhibitorsBolun Zhou, Lin Li, Fan Zhang, et al.
Pharmacological Research|September 14, 2023
Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non-small cell lung cancerWei Guo, Bolun Zhou, Liang Zhao, et al.
Translational Lung Cancer Research|September 12, 2022
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodesBolun Zhou, Ruochuan Zang, Moyan Zhang, et al.
Ebiomedicine|September 18, 2022
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancerBolun Zhou, Fenglong Bie, Ruochuan Zang, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2022
Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancerWei Guo, Qilin Huai, Bolun Zhou, et al.
Journal of Cellular and Molecular Medicine|September 3, 2019
Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancersWei Zhu, Bolun Zhou, Chenxuan Zhao, et al.
Pageof 5